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Field trial of a rapid card test for
Wuchereria bancrofti
David O Freedman, Adriana de Almeida, Janaina Miranda,
D Adam Plier, Cynthia Braga
Elimination of lymphatic filariasis, which infects 120 million
people worldwide, is now thought to be feasible.1 In order for
control programmes to be designed around a strategy of
community diagnosis and repeated annual mass
chemotherapy, efficient surveillance procedures will be
needed.2 Testing for circulating filarial antigen has now
emerged as the method of choice for the detection of
Wuchereria bancrofti infections.3 ELISA-based antigen testing
can be done on blood collected at any time of day or night, but
is not easy to do in the field. In retrospective testing of frozen
serum, a self-contained 5 min immunochromatographic card
test for filarial antigen (ICT Diagnostics, Balgowlah, Australia)
has been shown to be comparable to ELISA.3 We report on a
trial of the card test under field conditions.
We studied 847 residents of a W bancrofti-endemic
community of Recife, Brazil. In the card test, 50 µL of
untreated daytime serum are added to a small pad on the
7·56·5 cm card which has dried colloidal-gold-labelled
polyclonal antifilarial antibodies. Addition of two drops of
buffer to the card allows antibody and antigen (if present) to
flow across a nitrocellulose strip precoated with a monoclonal
antifilarial antibody. Positive serum samples cause a pink line
that is read by eye in the field and each card is labelled as a
permanent record. Specificity of the card test has been shown
to be greater than 99%.3 Prevalence of infection in men and
women was higher than had previously been reported from any
community in the greater Recife area (table).4 Further blood
was obtained from a sample of those studied with both positive
and negative card tests for direct comparison with other
methods. Had we conducted the survey with the surveillance
technique most widely used in control programmes—
examination of stained thick films of night blood specimens—
we would have underestimated infection prevalence by 
more than four-fold in this population. Use of the more
cumbersome technique of membrane filtration of night blood
specimens decreased sensitivity by 50%. The card test was
slightly less sensitive than ELISA. Serum that had been tested
then frozen and thawed gave the same results when re-tested
by card assay.
The rapid card test for filarial antigen requires no additional
equipment, so can be carried out under true field conditions.
The test should facilitate implementation of new strategies
proposed by WHO for the control and elimination of
lymphatic filariasis.2
This work was supported by grant AI-31552 from the US National
Institutes of health.
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Men Women Total
Infection prevalence (card 69/266 (25·9) 82/581 (14·1) 151/847 (17·8)
positivity; %)
Age, all (mean; range in yr) 29·5 (4–80) 33·6 (5–85) 32·3 (4–85)
Age, testing positive 28·3 (6–66) 27·6 (8–70) 27·9 (6–70)
Positive card Negative card
test* test†
Thick-film positive5 7/29 0/4
Membrane-filtration positive5 10/20 Not done
ELISA positive (TropBio, 43/43 2/34
Australia)
Post-thaw card test positive 31/31 0/13
*Denominator is sample of individuals who tested positive by card test. †Denominator
is sample of individuals who tested negative by card test.
Performance of filariasis antigen card test
Exhaled nitric oxide during lung
transplantation
Nándor Marczin, Bernhard Riedel, Janos Gal, Julia Polak, 
Magdi Yacoub
In lung transplantation, the lungs are vulnerable to injury
during harvesting, preservation, and reperfusion.1 The
mechanisms of this injury may involve the lung’s capacity to
generate nitric oxide (NO).2 Production of NO contributes to
co-ordination of ventilation/perfusion and to host defence by
interference with bacterial and viral growth, or to regulation
of inflammatory processes.3 Inhalation of NO in lung-
transplant recipients has been reported to be associated with
favourable pulmonary haemodynamics, gas exchange,
reduced duration of mechanical ventilation and mortality.4
However, little is known about endogenous NO production.
We monitored the exhaled NO concentrations intra-
operatively and postoperatively in lung transplantation.
Breath-to-breath analysis of airway NO concentration was
with a real-time, computer-controlled, and integrated system
(Logan Research Ltd 2000 series). For the duration of the
measurement, ventilation was standardised and NO and
cabon dioxide were sampled for 80 s as we have previously
described.5 Five representative cycles were analysed for peak
(NOP) or mean exhaled NO levels (NOM).
We studied 17 patients undergoing lung transplantation
who had cystic fibrosis, Eisenmenger’s syndrome, primary
pulmonary hypertension, sarcoidosis, histiocytosis X, or
emphysema. They received either heart-lungs (ten),
sequential bilateral lungs (five), or single-lung allografts
(two) from cadavers. The donors (mean age 34·3 years) had
subarachnoid haemorrhage, primary brain tumour, or
traumatic head injury. To investigate the effects of
harvesting, preservation, and reperfusion on exhaled NO,
measurements were made after completion of the airway
anastomoses both before and after reperfusion of the
pulmonary vascular bed. Patients undergoing open-heart
surgery for coronary bypass grafting served as controls with
measurements done before, during, and after cardio-
pulmonary bypass.
Baseline intraoperative exhaled NO in the native lungs of
the transplant recipients were variable. Patients with cystic
fibrosis and one patient with histiocytosis had very low NO.
By contrast, patients with Eisenmenger’s syndrome or
primary pulmonary hypertension had high exhaled NO
(NOP: 6·7 [SD 1·6] ppb; NOM: 3·9 [0·9] ppb). Analysis of
exhaled NO before and after reperfusion of the vascular bed
of the donor lungs showed three types of responses. Type I
response was characterised by a detectable NO signal before
reperfusion (n=4/17; NOP: 2·0 [0·3] ppb; NOM: 1·4 [0·2]
ppb) which remained unchanged during reperfusion and
24 h after early postoperative period (NOP: 2·3 [0·4] ppb;
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NOM: 1·5 [0·3] ppb). In type II responses (n=4/17) NO was
detected before reperfusion (NOP: 4·8 [1·2] ppb; NOM: 3·1
[0·8] ppb), however, reperfusion diminished exhaled NO
(NOP: 1·1 [0·4] ppb; NOM: 0·7 [0·4] ppb, p<0·05, figure).
This attenuation was transient, because NO tended to
increase towards prereperfusion levels within 24 h (NOP: 2·5
[0·3] ppb; NOM: 1·5 [0·1] ppb, figure, post-transplant).
Patients with type III responses (n=9/17) had low exhaled
NO both before and after reperfusion (NOP: 0·7 [0·1] ppb;
NOM: 0·3 [0·1] ppb). In these patients, a gradual recovery of
exhaled NO levels was seen in the postoperative period (3–14
days). We measured exhaled NO in patients undergoing
open-heart surgery before, during, and after cardio-
pulmonary bypass (CPB). All ten patients investigated had a
type I response with no change of exhaled NO during and
after CPB bypass (NOP: 9·0 [1·5] ppb and 8·1 [1·1] vs 8·2
[1·6] ppb and NOM: 5·7 [1·0] and 4·6 [0·6] vs 4·7 [1·0] ppb,
respectively).
Alveolar-arterial oxygen concentration gradient (measured
6 h after transplantation) was 96 (41–150), 326 (135–537),
and 352 (100–642) mm Hg for patients with type I, II, and
III responses. No patient died in type I, whereas mortality
was one (25%) of four and three (33%) of nine in type II and
type III, respectively. Among the surviving patients, the
average requirement for mechanical ventilation was 19·5
(8–31), 37 (4–79), and 121 (1–500) h for type I, II, and III.
Similarly, average intensive-care unit stay was 45 (34–52), 63
(21–91), and 252 (32–1032) h in these patients. Two patients
required NO inhalation for severe allograft dysfunction in
type III category, whereas this was not judged to be necessary
in any of the patients with type I and II responses.
This study suggests that during the perioperative period,
endogenous production of NO by cadaver lung allografts is
substantially diminished and follows one of three patterns
which appears to correlate with clinical behaviour.
Perioperative monitoring of exhaled NO might provide a
useful new method for the assessment of donor preservation
and evaluating strategies to modulate reperfusion injury.
Furthermore, the loss of NO in the perioperative period 
may provide a rationale for interventions aimed at restoring
endogenous NO production or replenishment by intravenous
NO donors or inhaled exogenous NO.
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Penile rigidity in erectile
dysfunction treated with alprostadil
Ermanno Greco, Paolo Polonio-Balbi
Clinical efficacy of transurethral alprostadil has been tested
by evaluating the penile response with systems such as the
Erection Assessment Scale, although several studies indicate
that penile rigidity assessed by an objective method is the
only valid way to test the efficacy of any treatment. We
evaluated the efficacy of transurethral alprostadil by assessing
both axial and radial rigidity.
123 patients, aged 33–77 years were studied. Alprostadil
was inserted into the distal urethra with a drug delivery
system (MUSE, Vivus, CA, USA) according to the
instructions of the manufacturer. After administration of the
drug, a colour-doppler device detected the passage of the
drug into the cavernous bodies through the increase of the
blood flow in the penile arteries. Axial rigidity was assessed
by penile buckling test—positive when a downward axially-
directed strength of 1 kg did not buckle the penis. Radial
rigidity was assessed by an electronic rigidometer
RIGICOMPT (Androsystems, Rome, Italy), with a pressure
transducer in contact with the side wall of the penis, to
measure its hardening.4 Rigidity was judged to be complete
when pressure was more than 75 mm Hg after visual erotic
stimulation. Almost all the patients (n=117) had previously
been on intracavernous insections; six patients had not 
had any treatment. Ten patients received the 250 µg, the rest
500 µg dosage as the first dose.
All patients had an improvement of arterial inflow which
was detected by the doppler proving the passage of the drug
into the corpora cavernosa. There was complete rigidity in 11
men; and a full but not a lasting erection (1–2 min) in 16.
There was an increase in volume, up to 114%, in almost all
patients, but not many had a real and lasting hardness. There
seems to be no correlation between volume increase and
hardness. Five patients wished to try the system at home, 
two of them got good results, the rest wished to stay on
intracavernous injections.
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Figure 1: Representative type II response of exhaled NO and
CO2 in a heart-lung transplant recipient for cystic fibrosis 
Traces depict: low exhaled NO levels by the native lungs of the
recipient; normal NO levels by the transplanted lungs before reperfusion
(exhaled CO2 levels are low because of cardiopulmonary bypass);
diminshed NO levels post reperfusion; and partial recovey 24 h after
transplantation.
